GC Biopharma Corp.
http://www.globalgreencross.com/eng/index.do
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From GC Biopharma Corp.
China Biotech CEO Podcast: CANbridge’s Xue On Orphan Drug Coverage, Financing, Gene Therapy
While many of his peers elbowed each other to leap into oncology, James Xue decided to focus on rare diseases such as Hunter’s Syndrome. Now, 10 years after founding CANbridge, the CEO sat down for an audio interview with Scrip to offer his views on a flurry of key issues impacting orphan drug development in potentially the world's largest pharma market.
US FDA’s 2022 Novel Agent Actions Suggest Acceleration In Use Of Complete Response Letters
COVID does not appear to be a driving factor, and letters are split almost equally between clinical and quality concerns.
Keeping Track: US FDA Approves Carvykti, Vonjo, But Turns Down Lenacapavir, Filsuvez And GC1507
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
WHO Biomanufacturing Training Hub Plan Offers Korea Chance On World Stage
South Korea welcomes WHO decision to designate the country as a global biomanufacturing training hub, citing various opportunities this could provide in fulfilling its goal of becoming a similar center of worldwide expertise in vaccines.
Company Information
- Industry
- Biotechnology
- Distributors
- Pharmaceuticals
- Contract Manufacturing Organization
- Other Names / Subsidiaries
-
- Ceragem Medisys
- Green Cross LabCell
- Green Cross Corporation
- GC Pharma